Jan 24, 2024, 01:00 AM by User Not Found

Bio-IT World | Taking a cue from Mother Nature, researchers from The University of Texas at El Paso are exploring the use of carbon nanoparticles synthesized from caffeic acid found in coffee grounds as a preventative or therapeutic agent for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Their work marks the first time caffeic acid has been used to create carbon quantum dots and the approach is not only economical and sustainable but also potentially interventional.

Jan 23, 2024, 08:18 AM by

Inizio Evoke delivers more connected solutions for clients to address demands of dynamic global healthcare marketplace

Jan 23, 2024, 08:18 AM by

Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds.

Jan 23, 2024, 08:18 AM by

Jan 23, 2024, 08:18 AM by

STEMart announced the launch of its new Force Degradation Services.

Jan 23, 2024, 08:18 AM by

CD BioSciences has announced new services to study mTOR.

Jan 23, 2024, 08:18 AM by

Jan 23, 2024, 08:18 AM by

HighRun DataScience announced statistical and data science services to empower retail businesses.

Jan 23, 2024, 01:00 AM by User Not Found

Bio-IT World | Stanford Medicine investigators are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age. Among the potential applications are screening people for conditions such as heart failure and Alzheimer’s disease, personalizing the intervention they’re prescribed, and signaling sooner the efficacy of investigational drugs based on how well they rejuvenate certain organs.

Jan 22, 2024, 08:54 AM by

Jan 22, 2024, 08:54 AM by

A breakthrough technology PGA brings gene-to-drug revolution in life.

Jan 22, 2024, 08:54 AM by

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Montgomeryville, Pennsylvania, January 18, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Jan 19, 2024, 09:05 AM by

Onyx Scientific plans to drive forward its latest US expansion plans with the appointment of Anthony Harbour as Business Development Manager in North America

Jan 18, 2024, 08:49 AM by

Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing